The contribution of HIV infection to intracranial arterial remodeling: A pilot study

Neuropathology

Volumn 33, Issue 3, 2013, Pages 256-263

  Gutierrez, Jose ^a   Elkind, Mitchell S V ^a,b   Petito, Carol ^d   Chung, David Y ^a   Dwork, Andrew J ^c   Marshall, Randolph S ^a  

^a Columbia University ^*  (United States)

^b Columbia University New York ^*  (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Arterial layers; Arterial remodeling; Dolichoectasia; HIV; Stroke

Indexed keywords

COCAINE;

ADULT; ADVENTITIA; ANTERIOR CEREBRAL ARTERY; ARTERIAL CIRCULATION; ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ARTERY DILATATION; ARTERY INTIMA; ARTERY MEDIA; ARTERY OCCLUSION; ARTERY WALL; ARTICLE; BASILAR ARTERY; BRAIN ARTERY; BRAIN WEIGHT; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERTENSION; INTERNAL CAROTID ARTERY; INTRACRANIAL ARTERY REMODELING; ISCHEMIC CARDIOMYOPATHY; MALE; MIDDLE CEREBRAL ARTERY; MINERALIZATION; NEGRO; ORGAN DONOR; PILOT STUDY; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; VERTEBRAL ARTERY;

AFRICAN CONTINENTAL ANCESTRY GROUP; CEREBRAL ARTERIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; PILOT PROJECTS; VASCULAR STIFFNESS; VASODILATION;

EID: 84878655915     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2012.01358.x     Document Type: Article

References (36)

1. Palella FJ Jr, Baker RK, Moorman AC etal. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43: 27-34.
2. Friis-Moller N, Reiss P, Sabin CA etal. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007; 356: 1723-1735.
3. Dube MP, Lipshultz SE, Fichtenbaum CJ, Greenberg R, Schecter AD, Fisher SD. Effects of HIV infection and antiretroviral therapy on the heart and vasculature. Circulation 2008; 118: e36-e40.
4. Currier JS, Lundgren JD, Carr A etal. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 2008; 118: e29-e35.
5. Cole JW, Pinto AN, Hebel JR etal. Acquired immunodeficiency syndrome and the risk of stroke. Stroke 2004; 35: 51-56.
6. Connor MD, Lammie GA, Bell JE, Warlow CP, Simmonds P, Brettle RD. Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke 2000; 31: 2117-2126.
7. Ortiz G, Koch S, Romano JG, Forteza AM, Rabinstein AA. Mechanisms of ischemic stroke in HIV-infected patients. Neurology 2007; 68: 1257-1261.
8. Gutierrez J, Ortiz G. HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: a case series. Clin Neuroradiol 2011; 21: 145-151.
9. Gutierrez J, Sacco RL, Wright CB. Dolichoectasia-an evolving arterial disease. Nat Rev Neurol 2011; 7: 41-50.
10. Gutierrez J, Glenn M, Isaacson R, Marr D, Mash D, Petito C. Thinning of the arterial media layer as a possible preclinical stage in HIV vasculopathy: a pilot study. Stroke 2012; 43: 1156-1158.
11. Sho E, Nanjo H, Sho M etal. Arterial enlargement, tortuosity, and intimal thickening in response to sequential exposure to high and low wall shear stress. J Vasc Surg 2004; 39: 601-612.
12. Masuda H, Zhuang YJ, Singh TM etal. Adaptive remodeling of internal elastic lamina and endothelial lining during flow-induced arterial enlargement. Arterioscler Thromb Vasc Biol 1999; 19: 2298-2307.
13. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371-1375.
14. Littell RC, Pendergast J, Natarajan R. Modelling covariance structure in the analysis of repeated measures data. Stat Med 2000; 19: 1793-1819.
15. Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol 2000; 31: 374-379.
16. Tipping B, de Villiers L, Wainwright H, Candy S, Bryer A. Stroke in patients with human immunodeficiency virus infection. J Neurol Neurosurg Psychiatry 2007; 78: 1320-1324.
17. Dubrovsky T, Curless R, Scott G etal. Cerebral aneurysmal arteriopathy in childhood AIDS. Neurology 1998; 51: 560-565.
18. Eugenin EA, Morgello S, Klotman ME etal. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol 2008; 172: 1100-1111.
19. Hoi Y, Gao L, Tremmel M etal. In vivo assessment of rapid cerebrovascular morphological adaptation following acute blood flow increase. J Neurosurg 2008; 109: 1141-1147.
20. Gasser TC, Ogden RW, Holzapfel GA. Hyperelastic modelling of arterial layers with distributed collagen fibre orientations. J R Soc Interface 2006; 3: 15-35.
21. Conaldi PG, Serra C, Dolei A etal. Productive HIV-1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin-1 beta plus tumor necrosis factor-alpha. J Med Virol 1995; 47: 355-363.
22. Wolf K, Tsakiris DA, Weber R, Erb P, Battegay M. Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1. J Infect Dis 2002; 185: 456-462.
23. Hsue PY, Lo JC, Franklin A etal. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004; 109: 1603-1608.
24. Ren Z, Yao Q, Chen C. HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells. Lab Invest 2002; 82: 245-255.
25. Zietz C, Hotz B, Sturzl M, Rauch E, Penning R, Lohrs U. Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. Am J Pathol 1996; 149: 1887-1898.
26. Passero SG, Rossi S. Natural history of vertebrobasilar dolichoectasia. Neurology 2008; 70: 66-72.
27. Pico F, Labreuche J, Gourfinkel-An I, Amarenco P. Basilar artery diameter and 5-year mortality in patients with stroke. Stroke 2006; 37: 2342-2347.
28. Milandre L, Bonnefoi B, Pestre P, Pellissier JF, Grisoli F, Khalil R. (Vertebrobasilar arterial dolichoectasia. Complications and prognosis). Rev Neurol (Paris) 1991; 147: 714-722.
29. Kwon HM, Kim JH, Lim JS, Park JH, Lee SH, Lee YS. Basilar artery dolichoectasia is associated with paramedian pontine infarction. Cerebrovasc Dis 2009; 27: 114-118.
30. Nakatomi H, Segawa H, Kurata A etal. Clinicopathological study of intracranial fusiform and dolichoectatic aneurysms: insight on the mechanism of growth. Stroke 2000; 31: 896-900.
31. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994; 330: 1431-1438.
32. Heil M, Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res 2004; 95: 449-458.
33. Hegedus K, Molnar P. Age-related changes in reticulin fibers and other connective tissue elements in the intima of the major intracranial arteries. Clin Neuropathol 1989; 8: 92-97.
34. Pasterkamp G, Schoneveld AH, van Wolferen W etal. The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system. A postmortem study. Arterioscler Thromb Vasc Biol 1997; 17: 3057-3063.
35. Gutierrez J, Gardener H, Bagci A etal. Dolichoectasia and intracranial arterial characteristics in a race-ethnically diverse community-based sample: the northern manhattan study. Stroke 2011; 42: e118.
36. Gutierrez J, Yoo C. Stroke prediction in a sample of HIV/AIDS patients: logistic regression, Bayesian networks or a combination of both? In: 19th international congress on modelling and simulation 2011; Perth, Australia. 2011. p. 1030-1036. (Cited 23 September 2012.) Available from URL: http://mssanz.org.au/modsim2011.